Prosecution Insights
Last updated: October 04, 2026

The Open University

Technology area: Biotechnology & Pharmaceuticals

3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready

Analysis

The Open University is currently addressing 3 pending office actions in the Biotechnology & Pharmaceuticals sector. While these actions are distributed across 3 distinct examiners, they are all contained within 1 distinct art unit, suggesting a thematic consistency in the technology being examined. This structure indicates that while the university is dealing with multiple individuals, the underlying technical standards and art unit policies remain uniform. Practitioners should note that managing 3 distinct examiners within a single unit can lead to varied interpretations of the same technical field.

VANWORMER, SKYLAR K is the busiest examiner for the university with 1 pending office action. Because the pending actions are split among different examiners, the workload is distributed despite the concentration in a single art unit. The presence of the 1 pending office action with VANWORMER, SKYLAR K requires a specific tactical approach tailored to that examiner's history, even as the broader strategy remains focused on the standards of the single art unit involved.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
1
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (33%)
2
Medium (67%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (67%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VANWORMER, SKYLAR K 1 46.9% +28.1%
RICCI, CRAIG D 1 53.5% +52.7%
LOVE, TREVOR M 1 43.0% +26.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18265933 COMBINATION THERAPY COMPRISING UNCARIA FOR TREATING ANXIETY AND DEPRESSION RICCI, CRAIG D 12d

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18008996 SHAN-ZHA FOR THE TREATMENT OF DEPRESSION AND ANXIETY DISORDERS LOVE, TREVOR M 5d overdue
18265933 COMBINATION THERAPY COMPRISING UNCARIA FOR TREATING ANXIETY AND DEPRESSION RICCI, CRAIG D 12d
18289470 ANALOG ONLINE LEARNING CIRCUIT VANWORMER, SKYLAR K —

Top Art Units

Art UnitApps
1611 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18289470 ANALOG ONLINE LEARNING CIRCUIT VANWORMER, SKYLAR K — §103 Non-Final OA — Pending Nov 03, 2023
18265933 COMBINATION THERAPY COMPRISING UNCARIA FOR TREATING ANXIETY AND DEPRESSION RICCI, CRAIG D 1611 §102§103 Final Rejection 12d Pending Jun 07, 2023
18008996 SHAN-ZHA FOR THE TREATMENT OF DEPRESSION AND ANXIETY DISORDERS LOVE, TREVOR M 1611 §103 Final Rejection 5d overdue Pending Dec 08, 2022

Managing The Open University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month